LicianPro

Veradermics, Inc ·

MANE 8-K 2026-11-10

Veradermics, Inc (MANE) 8-K dated 2026-11-10 — accession 0001827635-26-000041.

Veradermics, Inc (MANE) common stock.

MANE: Veradermics Reports Third Quarter 2026 Financial Results and Highlights…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for MANE is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The MANE SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

Guidance
expects to report topline data in the first half of 2027.

Why it matters

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr